Rigorous Free Energy Simulations in Virtual Screening

被引:120
作者
Cournia, Zoe [1 ]
Allen, Bryce K. [2 ]
Beuming, Thijs [3 ]
Pearlman, David A. [4 ]
Radak, Brian K. [2 ]
Sherman, Woody [2 ]
机构
[1] Acad Athens, Biomed Res Fdn, Athens 11527, Greece
[2] Silicon Therapeut, Boston, MA 02210 USA
[3] Latham BioPharm Grp, Cambridge, MA 02142 USA
[4] QSimulate Inc, Cambridge, MA 02139 USA
关键词
ACCELERATED MOLECULAR-DYNAMICS; BINDING FREE-ENERGIES; MONTE-CARLO SIMULATIONS; DATA FUSION; KINASE INHIBITORS; SIMILARITY SEARCH; SCORING FUNCTIONS; LIGAND COMPLEXES; ACCURATE DOCKING; ACTIVE-SITE;
D O I
10.1021/acs.jcim.0c00116
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Virtual high throughput screening (vHTS) in drug discovery is a powerful approach to identify hits: when applied successfully, it can be much faster and cheaper than experimental high-throughput screening approaches. However, mainstream vHTS tools have significant limitations: ligand-based methods depend on knowledge of existing chemical matter, while structure-based tools such as docking involve significant approximations that limit their accuracy. Recent advances in scientific methods coupled with dramatic speedups in computational processing with GPUs make this an opportune time to consider the role of more rigorous methods that could improve the predictive power of vHTS workflows. In this Perspective, we assert that alchemical binding free energy methods using all-atom molecular dynamics simulations have matured to the point where they can be applied in virtual screening campaigns as a final scoring stage to prioritize the top molecules for experimental testing. Specifically, we propose that alchemical absolute binding free energy (ABFE) calculations offer the most direct and computationally efficient approach within a rigorous statistical thermodynamic framework for computing binding energies of diverse molecules, as is required for virtual screening. ABFE calculations are particularly attractive for drug discovery at this point in time, where the confluence of large-scale genomics data and insights from chemical biology have unveiled a large number of promising disease targets for which no small molecule binders are known, precluding ligand-based approaches, and where traditional docking approaches have foundered to find progressible chemical matter.
引用
收藏
页码:4153 / 4169
页数:17
相关论文
共 148 条
  • [1] Role of the active-site solvent in the thermodynamics of factor Xa ligand binding
    Abel, Robert
    Young, Tom
    Farid, Ramy
    Berne, Bruce J.
    Friesner, Richard A.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (09) : 2817 - 2831
  • [2] Improving classical scoring functions using random forest: The non-additivity of free energy terms' contributions in binding
    Afifi, Karim
    AI-Sadek, Ahmed Farouk
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 92 (02) : 1429 - 1434
  • [3] Accurate calculation of the absolute free energy of binding for drug molecules
    Aldeghi, Matteo
    Heifetz, Alexander
    Bodkin, Michael J.
    Knappcd, Stefan
    Biggin, Philip C.
    [J]. CHEMICAL SCIENCE, 2016, 7 (01) : 207 - 218
  • [4] Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
    Allen-Petersen, Brittany L.
    Sears, Rosalie C.
    [J]. BIODRUGS, 2019, 33 (05) : 539 - 553
  • [5] Emerging Methods for Ensemble-Based Virtual Screening
    Amaro, Rommie E.
    Li, Wilfred W.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (01) : 3 - 13
  • [6] Åqvist J, 2001, COMB CHEM HIGH T SCR, V4, P613
  • [7] Structure-Based Virtual Screening, Molecular Dynamics and Binding Free Energy Calculations of Hit Candidates as ALK-5 Inhibitors
    Araujo, Sheila C.
    Maltarollo, Vinicius G.
    Almeida, Michell O.
    Ferreira, Leonardo L. G.
    Andricopulo, Adriano D.
    Honorio, Kathia M.
    [J]. MOLECULES, 2020, 25 (02):
  • [8] Analogue quantum chemistry simulation
    Argueello-Luengo, Javier
    Gonzalez-Tudela, Alejandro
    Shi, Tao
    Zoller, Peter
    Cirac, J. Ignacio
    [J]. NATURE, 2019, 574 (7777) : 215 - +
  • [9] Quantum supremacy using a programmable superconducting processor
    Arute, Frank
    Arya, Kunal
    Babbush, Ryan
    Bacon, Dave
    Bardin, Joseph C.
    Barends, Rami
    Biswas, Rupak
    Boixo, Sergio
    Brandao, Fernando G. S. L.
    Buell, David A.
    Burkett, Brian
    Chen, Yu
    Chen, Zijun
    Chiaro, Ben
    Collins, Roberto
    Courtney, William
    Dunsworth, Andrew
    Farhi, Edward
    Foxen, Brooks
    Fowler, Austin
    Gidney, Craig
    Giustina, Marissa
    Graff, Rob
    Guerin, Keith
    Habegger, Steve
    Harrigan, Matthew P.
    Hartmann, Michael J.
    Ho, Alan
    Hoffmann, Markus
    Huang, Trent
    Humble, Travis S.
    Isakov, Sergei V.
    Jeffrey, Evan
    Jiang, Zhang
    Kafri, Dvir
    Kechedzhi, Kostyantyn
    Kelly, Julian
    Klimov, Paul V.
    Knysh, Sergey
    Korotkov, Alexander
    Kostritsa, Fedor
    Landhuis, David
    Lindmark, Mike
    Lucero, Erik
    Lyakh, Dmitry
    Mandra, Salvatore
    McClean, Jarrod R.
    McEwen, Matthew
    Megrant, Anthony
    Mi, Xiao
    [J]. NATURE, 2019, 574 (7779) : 505 - +
  • [10] Using physics-based pose predictions and free energy perturbation calculations to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2
    Athanasiou, Christina
    Vasilakaki, Sofia
    Dellis, Dimitris
    Cournia, Zoe
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2018, 32 (01) : 21 - 44